Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-53 |
Sentence |
denotes |
Pitfalls in diagnosis and management of preeclampsia. |
TextSentencer_T2 |
54-112 |
Sentence |
denotes |
Hundreds of reports deal with the subject of preeclampsia. |
TextSentencer_T3 |
113-274 |
Sentence |
denotes |
A review of the world literature highlights the confusion and controversy regarding terminology, blood pressure measurements, diagnosis, and populations studied. |
TextSentencer_T4 |
275-405 |
Sentence |
denotes |
More than 100 clinical, biophysical, and biochemical tests have been recommended to predict the future development of the disease. |
TextSentencer_T5 |
406-582 |
Sentence |
denotes |
Results of the pooled data and the wide scatter therein suggest that none of these tests is sufficiently sensitive or specific for use as a screening test in clinical practice. |
TextSentencer_T6 |
583-740 |
Sentence |
denotes |
There is some evidence that nutritional supplementation or antithrombotic agents might reduce the incidence of preeclampsia, but the data are not conclusive. |
TextSentencer_T7 |
741-872 |
Sentence |
denotes |
In addition, the data do not suggest any benefit in perinatal outcome from the use of antihypertensive therapy in such pregnancies. |
TextSentencer_T8 |
873-1035 |
Sentence |
denotes |
The findings suggest that there is a definite need for standardization regarding definition, terminology, and diagnosis and for large multicenter clinical trials. |
TextSentencer_T9 |
1036-1106 |
Sentence |
denotes |
Finally, there is an urgent need to identify a marker of preeclampsia. |
T1 |
0-53 |
Sentence |
denotes |
Pitfalls in diagnosis and management of preeclampsia. |
T2 |
54-112 |
Sentence |
denotes |
Hundreds of reports deal with the subject of preeclampsia. |
T3 |
113-274 |
Sentence |
denotes |
A review of the world literature highlights the confusion and controversy regarding terminology, blood pressure measurements, diagnosis, and populations studied. |
T4 |
275-405 |
Sentence |
denotes |
More than 100 clinical, biophysical, and biochemical tests have been recommended to predict the future development of the disease. |
T5 |
406-582 |
Sentence |
denotes |
Results of the pooled data and the wide scatter therein suggest that none of these tests is sufficiently sensitive or specific for use as a screening test in clinical practice. |
T6 |
583-740 |
Sentence |
denotes |
There is some evidence that nutritional supplementation or antithrombotic agents might reduce the incidence of preeclampsia, but the data are not conclusive. |
T7 |
741-872 |
Sentence |
denotes |
In addition, the data do not suggest any benefit in perinatal outcome from the use of antihypertensive therapy in such pregnancies. |
T8 |
873-1035 |
Sentence |
denotes |
The findings suggest that there is a definite need for standardization regarding definition, terminology, and diagnosis and for large multicenter clinical trials. |
T9 |
1036-1106 |
Sentence |
denotes |
Finally, there is an urgent need to identify a marker of preeclampsia. |